This inventor holds 2 USPTO granted patents. Top assignee: Navigo Proteins Gmbh. Active years: 2025-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025-2026
Title: Eva Bosse-Doenecke: Innovator in Cancer Diagnosis and Treatment
Introduction
Eva Bosse-Doenecke is a prominent inventor based in Halle/Saale, US. She has made significant contributions to the field of cancer diagnosis and treatment through her innovative work. With a focus on developing novel binding proteins, her research aims to enhance the accuracy and effectiveness of cancer therapies.
Latest Patents
Eva holds a patent for "Novel FOLR1 Specific Binding Proteins for Cancer Diagnosis and Treatment." This patent represents her commitment to advancing medical science and improving patient outcomes. She has successfully secured 1 patent that showcases her expertise and dedication to innovation in the healthcare sector.
Career Highlights
Throughout her career, Eva has been associated with Navigo Proteins GmbH, where she has played a crucial role in research and development. Her work has not only contributed to the company's success but has also positioned her as a leader in her field. Eva's innovative spirit and scientific acumen have earned her recognition among her peers.
Collaborations
Eva has collaborated with notable colleagues, including Erik Fiedler and Ulrich Haupts. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the impact of their research.
Conclusion
Eva Bosse-Doenecke is a trailblazer in the realm of cancer diagnosis and treatment. Her innovative contributions and dedication to research continue to inspire advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile